Abstract
Background and Purpose- Disease management is a healthcare strategy that includes self-management education and treatment coordination. We conducted a randomized controlled trial to determine whether a disease management program intervention could improve risk factor profiles and, thus, reduce the recurrence of stroke and other cardiovascular diseases. Methods- This study is a prospective randomized, open-label, parallel group study involving outpatients with a history of stroke. Between September 2010 and November 2012, we enrolled patients aged between 40 and 80 years who experienced their last ischemic stroke event or transient ischemic attack within 1 year. After stratifying by the ischemic stroke subtype, 321 subjects (67.5±8.5 years, 95 female) were randomly assigned to either the disease management program intervention group (n=156) or the usual care group (n=165). The primary end point of this study was the difference in the Framingham risk score (general cardiovascular disease 10-year risk) from baseline. The secondary end points of this study included stroke recurrence, onset of cardiovascular disease, all-cause mortality, and all vascular events. Results- Regarding the primary end point, there was no significant diff...Continue Reading
References
Apr 1, 1990·Stroke; a Journal of Cerebral Circulation
Jun 3, 2004·Circulation·David P FaxonUNKNOWN American Heart Association's Expert Panel on Disease Management
Feb 18, 2005·Journal of Neurology, Neurosurgery, and Psychiatry·J HataM Iida
Aug 10, 2005·Circulation·J A IestraW A van Staveren
Aug 1, 2006·American Heart Journal·Scott A LearAndrew Ignaszewski
Oct 10, 2007·CMAJ : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne·Andrew WisterJoel Singer
Jan 24, 2008·Circulation·Ralph B D'AgostinoWilliam B Kannel
Apr 30, 2008·Health Policy·Oliver GappRolf Holle
May 21, 2009·BMJ : British Medical Journal·M R LawN J Wald
Oct 22, 2009·International Archives of Medicine·Shaheen E Lakhan, Michael T Sapko
Jan 26, 2011·Archives of Internal Medicine·Mats GullikssonKurt Svärdsudd
Aug 23, 2011·Circulation Journal : Official Journal of the Japanese Circulation Society·Shinya GotoUNKNOWN J-TRACE Investigators
Dec 6, 2012·Circulation·Mahshid DehghanUNKNOWN Ongoing Telmisartan Alone and in Combination With Ramipril Global End Point Trial (ONTARGET)/Telmisartan Randomized Assessme
Jan 4, 2013·PloS One·Stefanie LeistnerHeinrich J Audebert
Jan 30, 2014·NeuroRehabilitation·H M BossR M Van den Berg-Vos
Jan 13, 2015·Journal of Stroke and Cerebrovascular Diseases : the Official Journal of National Stroke Association·Yasuko FukuokaUNKNOWN DMP Stroke Trial Investigators
Oct 17, 2015·PloS One·Anna-Lotta IrewallThomas Mooe
Oct 27, 2015·EBioMedicine·Naohisa HosomiUNKNOWN J-STARS Collaborators
Oct 30, 2015·Circulation Journal : Official Journal of the Japanese Circulation Society·Tomohisa NezuUNKNOWN Japan Standard Stroke Registry Study Group
Dec 8, 2016·Stroke; a Journal of Cerebral Circulation·Inger A DeijleRenske M Van den Berg-Vos
Dec 25, 2016·Journal of Stroke and Cerebrovascular Diseases : the Official Journal of National Stroke Association
Jul 30, 2017·Stroke; a Journal of Cerebral Circulation·Muideen T OlaiyaAmanda G Thrift
Citations
Sep 22, 2020·EClinicalMedicine·Peter WilleitUNKNOWN STROKE-CARD study group
Feb 6, 2021·Postgraduate Medical Journal·Tao YouXiang Zhou
May 6, 2021·International Journal of Stroke : Official Journal of the International Stroke Society·Christian BoehmeStefan Kiechl
Jul 10, 2021·Journal of Primary Care & Community Health·Michiko MoriyamaMd Moshiur Rahman